Volume 33; Issue Sup 1

Oncology Times

Volume 33; Issue Sup 1
1

ACS Survey Uncovers Physician Concerns about Appropriate Survivor Care

Carlson, Robert H.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 710 KB
english, 2011
2

Advanced RCC: Second-Line Axitinib Extends Progression-Free Survival vs Sorafenib

Carlson, Robert H.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 730 KB
english, 2011
3

Assess for Distress: Nurses Best in Screening Overlooked Problem

Washam, Cynthia
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 471 KB
english, 2011
4

NSCLC: Pemetrexed Continuation Therapy Extends Progression-Free Survival

Carlson, Robert H.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 637 KB
english, 2011
5

Cancer-Related Fatigue: Exercise Remains Best Prevention and Treatment

Washam, Cynthia
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 393 KB
english, 2011
7

Lifestyle Impacts Risk of Four Major Cancers in Women at High Risk of Breast Cancer

Tuma, Rabiya S.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 568 KB
english, 2011
8

Exemestane Offers New Option to Prevent Breast Cancer in Postmenopausal Women

Fuerst, Mark
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 630 KB
english, 2011
9

Melanoma: Complete Remissions, Durable Responses, and a New Future for Patients and Research

Tuma, Rabiya S.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 1.03 MB
english, 2011
10

Improving Adherence to Oral Oncolytics

Lindsey, Heather
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 459 KB
english, 2011
11

Moving Personalized Medicine into Phase I Trials

Tuma, Rabiya S.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 641 KB
english, 2011
12

Breast Cancer: ‘Chemo Brain’ Associated with Circulating Tumor Necrosis Factor

Carlson, Robert H.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 625 KB
english, 2011
13

GIST: Longer Imatinib Treatment Cuts Risk of Recurrence, Death by Half

Carlson, Robert H.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 852 KB
english, 2011
14

ALK-Positive NSCLC: Crizotinib Extends Survival, Called New Standard of Care

Carlson, Robert H.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 726 KB
english, 2011
15

CLL: Novel Agents Promising in Patients with Poor Prognosis

Carlson, Robert H.
Journal:
Oncology Times
Year:
2011
Language:
english
File:
PDF, 768 KB
english, 2011